首頁 > 市場調查報告書 > 醫療設備

體外診斷感染疾病

市場調查報告書

商品編碼

1737093

全球 COVID-19檢測套組市場規模（按樣本類型、檢測類型、產品類型、最終用途、地區和預測）

Global COVID-19 Testing Kits Market Size By Sample Type (Nasopharyngeal Swab Oropharyngeal Swab, Nasal Swab), By Test Type (Molecular Testing, Antigen-based Testing), By Product Type, By End-Use, By Geographic Scope And Forecast

出版日期: 2025年05月08日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

COVID-19檢測套組市場規模及預測

2024 年 COVID-19檢測套組市場規模為 73.132 億美元，預計到 2032 年將達到 26.688 億美元，2026 年至 2032 年的複合年成長率為 13.06%。

COVID-19 檢測套件用於 SARS-CoV-2 的試管內診斷和鑑定。這些套件可在幾分鐘到幾小時內快速提供結果，有助於對患者照護。

在預測期內，改善患者照護、持續的技術進步以及對 COVID-19 檢測套件的需求增加可能會推動市場擴張。

由於大多數國家的大多數人口都接種了疫苗，新的 COVID-19 病例數量正在下降，這可能會阻礙未來幾年的市場成長。

大多數國家正在透過設立免下車或步行檢測中心來增加檢測地點的數量。

這些檢測中心將減少醫護人員的等待時間，並降低感染風險。對於冠狀病毒的識別，在家採集樣本的技術已成為更安全的選擇。

這些因素的相互作用帶來了供不應求和檢測地點有限的挑戰。

COVID-19檢測套組的全球市場動態

影響全球 COVID-19檢測套組市場的關鍵市場動態包括：

關鍵促進因素

全球大流行：COVID-19 的迅速蔓延增加了進行大規模檢測以有效識別、隔離和治療病例的需求。

政府措施：世界各地的許多政府都要求定期進行檢測，從而推動了整個醫療保健系統和產業檢測套組的需求。

技術進步：根據世界衛生組織（WHO）的數據，截至2024年，全球已發現100多種SARS-CoV-2變異株。根據美國疾病管制與預防中心（CDC）的報告，2021年美國，即Omicron變異株出現之時，美國平均每天進行160萬次檢測，比2021年10月增加了300%。 RT-PCR、快速抗原和抗體檢測等檢測方法的創新提高了準確性並縮短了檢測時間。

提高意識：人們對早期檢測和預防的認知不斷提高，這使得大眾需要能夠輕鬆獲得的檢測套組。

商業和旅行限制：旅行、職場和活動必須進行檢測，這增加了對檢測套組的需求。

主要挑戰

供應鏈中斷：全球原料短缺和製造瓶頸導致檢測套組的生產和分發延遲。

準確性和可靠性問題：一些快速檢測因與黃金標準 RT-PCR 檢測相比準確性較低而受到批評。

不斷進化的病毒株：COVID-19 新變種的出現引發了人們對檢測準確性和對抗突變有效性的擔憂。

檢測成本高：頻繁檢測，尤其是在低收入地區，對大規模、持續的檢測構成了經濟挑戰。

競爭和產能過剩：大量公司湧入市場，導致價格波動和對品管的擔憂。

主要趨勢

家用檢測套組：對於可在家中方便進行的自我檢測套組的需求顯著增加。

快速檢測：快速抗原檢測因能在幾分鐘內提供結果而廣受歡迎，是旅行或活動現場檢測的理想選擇。

即時診斷：專為診所或即時診斷而設計的檢測套組無需複雜的實驗室設備即可進行快速診斷。

與數位平台整合：許多檢測套組將與行動應用程式和數位平台整合，以便追蹤、驗證和報告結果。

專注於具有成本效益的解決方案：越來越多的公司正在開發低成本的測試解決方案，以便新興國家和服務不足地區能夠使用它們。

Technological Advancements: According to the World Health Organization (WHO), as of 2024, over 100 SARS-CoV-2 variants have been identified globally. The Centers for Disease Control and Prevention (CDC) reports that during the emergence of the Omicron variant, the U.S. conducted an average of 1.6 million tests per day in December 2021, a 300% increase from October 2021. Innovations in testing methods like RT-PCR, rapid antigen, and antibody tests improved accuracy and reduced testing time.

Rising Awareness: Increased awareness about early detection and prevention fueled the need for accessible testing kits for the general population.

Corporate and Travel Regulations: Mandatory testing for travel, workplaces, and events sustained demand for testing kits.

Key Challenges

Supply Chain Disruptions: Global shortages of raw materials and manufacturing bottlenecks created delays in test kit production and distribution.

Accuracy and Reliability Issues: Some rapid tests faced criticism over lower accuracy rates compared to gold-standard RT-PCR tests.

Evolving Virus Strains: The emergence of new COVID-19 variants led to concerns about test accuracy and effectiveness against mutations.

High Cost of Testing: Frequent testing, especially in low-income regions, posed affordability challenges for large-scale, continuous testing.

Competition and Overproduction: The rapid influx of players into the market caused price fluctuations and concerns about quality control.

Key Trends

At-Home Testing Kits: There was a significant rise in demand for self-testing kits, enabling convenient testing from home.

Rapid Testing: Rapid antigen tests gained popularity due to their ability to deliver results within minutes, ideal for on-the-spot testing in travel and events.

Point-of-Care Diagnostics: Testing kits designed for use in clinics and at point-of-care settings enabled quicker diagnostics without needing complex lab equipment.

Integration with Digital Platforms: Many testing kits are integrated with mobile apps and digital platforms for result tracking, verification, and reporting.

Focus on Cost-Effective Solutions: Companies increasingly developed low-cost testing solutions to ensure accessibility in developing countries and underserved regions.

Global Covid-19 Testing Kits Market Regional Analysis

Here is a more detailed regional analysis of the global COVID-19 testing kits market:

Asia Pacific

The Asia Pacific region has experienced significant growth in the Global COVID-19 Testing Kits Market, driven by rising infection rates and the urgent need for rapid and accurate testing solutions.

Governments across countries such as India, China, Japan, and Australia have implemented extensive testing protocols to contain the virus's spread, resulting in increased demand for various types of testing kits, including PCR, rapid antigen, and antibody tests.

The region's robust manufacturing capabilities have allowed local companies to scale up production and meet the surging demand for testing kits.

Collaborations between governments, healthcare organizations, and private companies have facilitated research and development efforts to enhance the accuracy and efficiency of testing solutions.

Increased public awareness about the importance of testing and monitoring COVID-19 infections has further propelled market growth.

As vaccination rates rise and the focus shifts toward managing the pandemic, the demand for COVID-19 testing kits is expected to evolve, with an emphasis on at-home testing and innovative technologies such as digital health platforms.

The Asia Pacific region is poised to play a crucial role in shaping the future of the COVID-19 testing kits market through continued innovation and collaboration.

North America

North America, is anticipated to witness the fastest growth in the Global COVID-19 Testing Kits Market during the forecast period driven by the urgent need for widespread testing during the pandemic.

The U.S. Department of Health and Human Services invested $785 million in 2024 to improve COVID-19 testing access for vulnerable and high-risk populations.

According to a survey by the College of American Pathologists, 72% of medical laboratories have expanded their molecular testing capabilities since 2020, with COVID-19 testing representing an average of 30% of their molecular diagnostics workload.

The U.S. Bureau of Labor Statistics projects a 7% growth in clinical laboratory technologist and technician jobs from 2021 to 2032, partly driven by continued COVID-19 testing demands.

The United States and Canada implemented aggressive testing strategies to manage the virus's spread, leading to increased demand for various testing kits, including PCR, rapid antigen, and antibody tests.

The U.S. Food and Drug Administration (FDA) played a crucial role in accelerating the approval process for testing kits, allowing manufacturers to bring their products to market quickly.

This expedited regulatory environment fostered innovation and competition among companies, resulting in a diverse range of testing solutions that cater to different needs, from laboratory-based tests to at-home testing kits.

Partnerships between public health agencies, research institutions, and private companies have enhanced the development and distribution of testing kits.

The region has also witnessed significant investments in research and development, aimed at improving the accuracy and efficiency of COVID-19 testing methods.

Global COVID-19 Testing Kits Market: Segmentation Analysis

The Global COVID-19 Testing Kits Market is Segmented based on Sample Type, Test Type, Product Type, End-Use, and Geography.

COVID-19 Testing Kits Market, By Sample Type

Nasopharyngeal (NP) Swab
Oropharyngeal (OP) Swab
Nasal Swab

Based on sample type, the Global COVID-19 Testing Kits Market is segmented into Nasopharyngeal (NP) Swabs, Oropharyngeal (OP) Swabs, and Nasal Swabs. The Nasopharyngeal (NP) Swab segment holds a significant share in the market owing to its high accuracy and widespread use in detecting viral infections. The Oropharyngeal (OP) Swab and Nasal Swab segments are also vital in diagnostic processes, providing alternatives in sample collection methods to accommodate patient comfort and clinical needs.

COVID-19 Testing Kits Market, By Test Type

Molecular (PCR) Testing
Antigen-based Testing
Antibody (Serology) Testing

Based on test type, the Global COVID-19 Testing Kits Market is segmented into Molecular (PCR) Testing, Antigen-based Testing, and Antibody (Serology) Testing. The Molecular (PCR) Testing segment dominates the Global COVID-19 Testing Kits Market owing to its high accuracy in detecting active infections by identifying the virus's genetic material.

COVID-19 Testing Kits Market, By Product Type

Reagents & Kits
Instruments
Service

Based on product type, the Global COVID-19 Testing Kits Market is segmented into Reagents & Kits, Instruments, and Services. The Reagents & Kits segment holds a significant share of the Global COVID-19 Testing Kits Market, driven by the need for mass testing to curb the spread of the virus.

COVID-19 Testing Kits Market, By End-Use

Laboratories, Hospitals
Diagnostic Centers and Clinics,
Research Institutes

Based on end-use, the global COVID-19 testing kits market is segmented into Laboratories, Hospitals, Diagnostic Centers and Clinics, and Research Institutes. The Laboratories and Hospitals segment dominates in the Global COVID-19 Testing Kits Market owing to the large-scale testing and treatment of COVID-19 patients in medical facilities.

COVID-19 Testing Kits Market, By Geography

North America
Europe
Asia Pacific
Rest of the world

Based on geography, the global COVID-19 testing kits market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The Asia Pacific region has experienced significant growth in the Global COVID-19 Testing Kits Market, driven by rising infection rates and the urgent need for rapid and accurate testing solutions. Governments across countries such as India, China, Japan, and Australia have implemented extensive testing protocols to contain the virus's spread, resulting in increased demand for various types of testing kits, including PCR, rapid antigen, and antibody tests. The region's robust manufacturing capabilities have allowed local companies to scale up production and meet the surging demand for testing kits.

Key Players

The "Global COVID-19 Testing Kits Market" study report provides valuable insight with an emphasis on the global market. The major players in the market are Hoffmann-La Roche AG, Abbott Laboratories, Thermo Fisher Scientific, Inc., PerkinElmer, Inc., 1drop, Inc., Veredus Laboratories, Altona Diagnostics GmbH (ADT Biotech Sdn Bhd), BGI, Cepheid BioFire Diagnostics, Co-Diagnostics, Inc, GenMark Diagnostics, Inc., Qiagen, Randox Laboratories Ltd, SD Biosensor.

This section offers in-depth analysis through a company overview, position analysis, the regional and industrial footprint of the company, and the ACE matrix for insightful competitive analysis. The section also provides an exhaustive analysis of the financial performances of mentioned players in the given market.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Covid-19 Testing Kits Market Key Developments

In July 2020, Mylab Discovery Solutions made the Pathocatch COVID-19 antigen fast testing kit available, developed in collaboration with LabCare Diagnostics, a Gujarat-based company. As a result of this progress, the company improved its market position.
In February 2021, Thermo Fisher Scientific announced the launch of the CE-IVD-Marked TaqPath COVID-19 HT Kit, a COVID-19 diagnostic assay compatible with the Amplitude platform, designed for high throughput and reliable, accurate testing. This product launch aided the corporation in gaining market share.

1 INTRODUCTION TO THE GLOBAL COVID19 TESTING KITS MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL COVID19 TESTING KITS MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porter Five Force Model
4.4 Value Chain Analysis

5 GLOBAL COVID19 TESTING KITS MARKET, BY SAMPLE TYPE

5.1 Overview
5.2 Nasopharyngeal (NP) Swab
5.3 Oropharyngeal (OP) Swab
5.4 Nasal Swab
5.5 Others

6 GLOBAL COVID19 TESTING KITS MARKET, BY TEST TYPE

6.1 Overview
6.2 Molecular (PCR) Testing
6.3 Antigen-based Testing
6.4 Antibody (Serology) Testing
6.5 Others

7 GLOBAL COVID19 TESTING KITS MARKET, BY END-USE

7.1 Overview
7.2 Laboratories
7.3 Hospitals
7.4 Diagnostic Centers and Clinics
7.5 Research Institutes

8 GLOBAL COVID19 TESTING KITS MARKET, BY PRODUCT TYPE

8.1 Overview
8.2 Reagents & Kits
8.3 Instruments
8.4 Service

9 GLOBAL COVID19 TESTING KITS MARKET, BY GEOGRAPHY

9.1 Overview
9.2 North America
- 9.2.1 The U.S.
- 9.2.2 Canada
- 9.2.3 Mexico
9.3 Europe
- 9.3.1 Germany
- 9.3.2 The U.K.
- 9.3.3 France
- 9.3.4 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Rest of Asia Pacific
9.5 Rest of the World
- 9.5.1 Latin America
- 9.5.2 Middle East and Africa

10 GLOBAL COVID19 TESTING KITS MARKET COMPETITIVE LANDSCAPE

10.1 Overview
10.2 Company Market Ranking
10.3 Key Development Strategies

11 COMPANY PROFILES

11.1 F. Hoffmann-La Roche AG
- 11.1.1 Overview
- 11.1.2 Financial Performance
- 11.1.3 Product Outlook
- 11.1.4 Key Developments
11.2 Abbott Laboratories
- 11.2.1 Overview
- 11.2.2 Financial Performance
- 11.2.3 Product Outlook
- 11.2.4 Key Developments
11.3 Thermo Fisher Scientific, Inc.
- 11.3.1 Overview
- 11.3.2 Financial Performance
- 11.3.3 Product Outlook
- 11.3.4 Key Developments
11.4 PerkinElmer, Inc.
- 11.4.1 Overview
- 11.4.2 Financial Performance
- 11.4.3 Product Outlook
- 11.4.4 Key Developments
11.51drop, Inc.
- 11.5.1 Overview
- 11.5.2 Financial Performance
- 11.5.3 Product Outlook
- 11.5.4 Key Developments
11.6 Veredus Laboratories
- 11.6.1 Overview
- 11.6.2 Financial Performance
- 11.6.3 Product Outlook
- 11.6.4 Key Developments
11.7 Altona Diagnostics GmbH (ADT Biotech Sdn Bhd)
- 11.7.1 Overview
- 11.7.2 Financial Performance
- 11.7.3 Product Outlook
- 11.7.4 Key Developments
11.8 BioFire Diagnostics
- 11.8.1 Overview
- 11.8.2 Financial Performance
- 11.8.3 Product Outlook
- 11.8.4 Key Developments
11.9 Co-Diagnostics, Inc
- 11.9.1 Overview
- 11.9.2 Financial Performance
- 11.9.3 Product Outlook
- 11.9.4 Key Developments
11.10 GenMark Diagnostics, Inc.
- 11.10.1 Overview
- 11.10.2 Financial Performance
- 11.10.3 Product Outlook
- 11.10.4 Key Developments
11.11 BGI
- 11.11.1 Overview
- 11.11.2 Financial Performance
- 11.11.3 Product Outlook
- 11.11.4 Key Developments
11.12 Qiagen
- 11.12.1 Overview
- 11.12.2 Financial Performance
- 11.12.3 Product Outlook
- 11.12.4 Key Developments
11.13 Randox Laboratories Ltd
- 11.13.1 Overview
- 11.13.2 Financial Performance
- 11.13.3 Product Outlook
- 11.13.4 Key Developments
11.14 SD Biosensor
- 11.14.1 Overview
- 11.14.2 Financial Performance
- 11.14.3 Product Outlook
- 11.14.4 Key Developments